Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Weitz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinomaCristina Salmerón, Elena Tomás Bort, Krishna Sriram, et al.
Cancer Research|June 28, 2023
Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal AdenocarcinomaKevin Christian Montecillo Gulay, Xinlian Zhang, Vasiliki Pantazopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2024
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS MutationsJonathan Weitz, Daisuke Nishizaki, Joy Liau, et al.
Nature Communications|July 24, 2020
Publisher Correction: Long-term culture of human pancreatic slices as a model to study real-time islet regenerationMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Jonathan Weitz, et al.
Nature Communications|July 1, 2020
Long-term culture of human pancreatic slices as a model to study real-time islet regenerationMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Jonathan Weitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2026
Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrugLaura Antonucci, Kosuke Watari, Yechen Feng, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2025
Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinomaCristina Salmerón, Elena Tomás Bort, Krishna Sriram, et al.
Cancer Research|June 28, 2023
Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal AdenocarcinomaKevin Christian Montecillo Gulay, Xinlian Zhang, Vasiliki Pantazopoulou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2024
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS MutationsJonathan Weitz, Daisuke Nishizaki, Joy Liau, et al.
Nature Communications|July 24, 2020
Publisher Correction: Long-term culture of human pancreatic slices as a model to study real-time islet regenerationMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Jonathan Weitz, et al.
Nature Communications|July 1, 2020
Long-term culture of human pancreatic slices as a model to study real-time islet regenerationMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Jonathan Weitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2026
Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrugLaura Antonucci, Kosuke Watari, Yechen Feng, et al.
Pageof 2